TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 72 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $7,271,000 | -47.0% | 49,065 | -45.0% | 0.13% | -50.2% |
| Q3 2014 | $13,715,000 | -2.9% | 89,138 | -11.5% | 0.27% | +2.3% |
| Q2 2014 | $14,124,000 | +27.2% | 100,711 | +0.6% | 0.26% | +25.8% |
| Q1 2014 | $11,108,000 | +14.9% | 100,072 | +2.4% | 0.21% | +16.8% |
| Q4 2013 | $9,665,000 | +63.9% | 97,729 | +26.0% | 0.18% | +57.0% |
| Q3 2013 | $5,896,000 | – | 77,583 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |